Bayesian Capital Management, LP - ABCELLERA BIOLOGICS INC ownership

ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of ABCELLERA BIOLOGICS INC
ValueSharesWeighting
Q2 2023$233,141
+63.7%
36,090
+91.1%
0.02%
+38.9%
Q1 2023$142,431
-60.3%
18,890
-46.6%
0.02%
-65.4%
Q4 2022$358,501
+3.9%
35,390
+1.4%
0.05%
-25.7%
Q3 2022$345,000
+21.1%
34,890
+30.2%
0.07%
+32.1%
Q2 2022$285,000
+5.6%
26,790
-3.3%
0.05%
+32.5%
Q1 2022$270,000
-46.4%
27,700
+21.0%
0.04%
-69.7%
Q2 2021$504,00022,9000.13%
Other shareholders
ABCELLERA BIOLOGICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Founders Fund VII Management, LLC 3,773,530$37,320,00092.58%
Gruss & Co., LLC 308,570$3,052,00026.27%
Founders Fund Growth Management, LLC 407,017$4,025,00011.55%
Belmont Capital, LLC 510,000$5,044,0005.95%
HARVARD MANAGEMENT CO INC 4,105,095$40,599,0005.05%
GUARDIAN CAPITAL ADVISORS LP 3,736,414$40,129,0005.01%
Intellectus Partners, LLC 1,091,505$10,795,0003.84%
ArchPoint Investors 617,213$6,104,0002.49%
BRANDYWINE MANAGERS, LLC 56,976$563,0001.85%
Casdin Capital, LLC 1,650,000$16,319,0001.07%
View complete list of ABCELLERA BIOLOGICS INC shareholders